Association of hypoxia inducible factor-1α polymorphisms with susceptibility to non-small-cell lung cancer. (Q54334905)

28 May 2018

title

Association of hypoxia inducible factor-1α polymorphisms with susceptibility to non-small-cell lung cancer. (English)

1 reference

28 May 2018

0 references

Wu-Hsien Kuo

1

1 reference

28 May 2018

Chuen-Ming Shih

2

1 reference

28 May 2018

Chiao-Wen Lin

3

1 reference

28 May 2018

Wei-Erh Cheng

4

1 reference

28 May 2018

Shuo-Chueh Chen

5

1 reference

28 May 2018

Wei Chen

6

1 reference

28 May 2018

Yao-Ling Lee

7

1 reference

28 May 2018

publication date

8 October 2011

1 reference

28 May 2018

published in

Translational Research

1 reference

28 May 2018

volume

159

1 reference

28 May 2018

issue

1

1 reference

28 May 2018

page(s)

42-50

1 reference

28 May 2018

Epidemiology of Lung Cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

7 January 2021

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Lung cancer epigenetics and genetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Additional candidates to conventional genes susceptible for lung cancer and changing trend in Japan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Update in lung cancer and mesothelioma 2009.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Hypoxia-inducible factors and hypoxic cell death in tumour physiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

HIF-1α Promotes A Hypoxia-Independent Cell Migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

The tumor microenvironment in non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Increased levels of hypoxia-inducible factor-1α are associated with Bcl-xL expression, tumor apoptosis, and clinical outcome in chondrosarcoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

The role of oxygen in regulating neural stem cells in development and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Hypoxia response pathway in border cell migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Hypoxia inducible factor-1 mediates expression of galectin-1: the potential role in migration/invasion of colorectal cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

[Tumor hypoxia: the role of HIF].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Hypoxia activates the cyclooxygenase-2-prostaglandin E synthase axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Hypoxia and metabolic phenotypes during breast carcinogenesis: expression of HIF-1alpha, GLUT1, and CAIX.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

VHL and HIF signalling in renal cell carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-κB promotes gastric tumour growth and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Hypoxia inducible factor-1α expression in areca quid chewing-associated oral squamous cell carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Prognostic significance of hypoxia-inducible factor-1alpha, TWIST1 and Snail expression in resectable non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Effect of hypoxia-inducible factor-1alpha on transcription of survivin in non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Hypoxia-inducible factor-1alpha polymorphisms and TSC1/2 mutations are complementary in head and neck cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Hypoxia-inducible factor-1alpha gene polymorphisms and cancer risk: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

The HIF-1alpha C1772T polymorphism may be associated with susceptibility to clinically localised prostate cancer but not with elevated expression of hypoxic biomarkers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Association of polymorphisms of angiogenesis genes with breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Hypoxia-inducible factor-1alpha (HIF-1alpha) gene polymorphisms, circulating insulin-like growth factor binding protein (IGFBP)-3 levels and prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Genetic variations in the hypoxia-inducible factor-1alpha gene and lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

C2028T polymorphism in exon 12 and dinucleotide repeat polymorphism in intron 13 of the HIF-1α gene define HIF-1α protein expression in non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Genetic variation in the hypoxia-inducible factor-1alpha gene is associated with type 2 diabetes in Japanese.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Hypoxia-inducible factor-1alpha polymorphisms associated with enhanced transactivation capacity, implying clinical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Identification of hypoxia-inducible factor-1alpha (HIF-1alpha) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Hypoxia-inducible factor-1α polymorphisms are associated with genetic aberrations in lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Associations between hypoxia-inducible factor-1alpha (HIF-1alpha) gene polymorphisms and risk of developing breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Single nucleotide polymorphisms in the hypoxia-inducible factor-1alpha (HIF-1alpha) gene in human sporadic breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Polymorphism in the hypoxia-inducible factor 1alpha gene may confer susceptibility to androgen-independent prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

The association between hypoxia inducible factor-1alpha gene polymorphisms and increased susceptibility to oral cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Polymorphisms in the hypoxia inducible factor 1-alpha and the impact on the prognosis of early stages of oral cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Association between ulcerative growth and hypoxia inducible factor-1alpha polymorphisms in colorectal cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Hypoxia-inducible factor 1α polymorphisms and early-stage cervical cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Prognostic significance of HIF-1 alpha polymorphisms in transitional cell carcinoma of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Common single nucleotide polymorphism of hypoxia-inducible factor-1alpha and its impact on the clinicopathological features of esophageal squamous cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

The prognostic value of hypoxia markers in T2-staged oral tongue cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Prognostic values of pathologic findings and hypoxia markers in 21 patients with salivary duct carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Clinicopathologic significance of HIF-1alpha, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Clinicopathological significance of nuclear factor-kappa B, HIF-1 alpha, and vascular endothelial growth factor expression in stage III colorectal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Hypoxia induced CCR7 expression via HIF-1alpha and HIF-2alpha correlates with migration and invasion in lung cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Upregulation of hypoxia-inducible factor-1alpha mRNA and its clinical significance in non-small cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Expression and clinical implication of HIF-1alpha and VEGF-C in non-small cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.003

10.1016/J.TRSL.2011.09.003

7 January 2021

Identifiers

DOI

1 reference

28 May 2018

PubMed ID

22153809

1 reference

28 May 2018